Establishing a higher priority for chronic kidney disease in Peru

The Lancet Global Health

Volumn 4, Issue 1, 2016, Pages e17-e18

  Francis, Elizabeth R ^a,b,c,d   Allen, Alexander K ^e,f   Herrera Añazco, Percy ^g,h   Kuo, Chin Chi ^c,i   Cardenas, Maria K ^d   Feldman, Harold I ^j   Baral, Stefan D ^c   Miranda, J Jaime ^d,k  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d CRONICAS CENTER OF EXCELLENCE IN CHRONIC DISEASES   (Peru)

^e PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^f NEW YORK UNIVERSITY   (United States)

^g UNIVERSIDAD NACIONAL DE PIURA   (Peru)

^h HOSPITAL NACIONAL DOS DE MAYO   (Peru)

ⁱ CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY DISEASE; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DISEASE COURSE; END STAGE RENAL DISEASE; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HEALTH INSURANCE; HEALTH PROGRAM; HEMODIALYSIS; HUMAN; HYPERTENSION; NOTE; PERITONEAL DIALYSIS; PERU; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SOCIAL SECURITY; ECONOMICS; HEALTH CARE POLICY; INSURANCE; RENAL INSUFFICIENCY, CHRONIC;

HEALTH CARE REFORM; HUMANS; PERU; RENAL INSUFFICIENCY, CHRONIC; UNIVERSAL COVERAGE;

EID: 84951854090     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(15)00206-5     Document Type: Note

References (13)

1. Francis ER, Kuo C, Bernabe-Ortiz A, et al. Burden of chronic kidney disease in Peru: a population-based study. BMC Nephrol 2015, 16:114.
2. Global Burden of Disease Profile: Peru Institute for Health Metrics and Evaluation, (accessed July 26, 2015). http://www.healthdata.org/sites/default/files/files/country_profiles/GBD/ihme_gbd_country_report_peru.pdf.
3. Cieza J, Huanman C, Alvarez C, et al. Prevelencia de insuficiencia renal crónica en la ciudad de Lima-Perú, Enero 1990. Rev Peru Epidemiol 1992, 5:22-27.
4. Haller M, Gutjahr G, Kramar R, et al. Cost-effectiveness analysis of renal replacement therapy in Australia. Nephrol Dial Transplant 2011, 9:2988-2995.
5. Supreme Decree N° 007-2012-TR Ministry of Labor, (accessed Aug 31, 2015). http://www.trabajo.gob.pe/archivos/file/SNIL/normas/2012-05-17_007-2012-TR_2289.pdf.
6. Hurtado A End stage renal failure and risk factors in Peru (accessed May 8, 2015). ftp://ftp2.minsa.gob.pe/donwload/esn/dnt/srenal/InsRenalPeru.pdf.
7. Vermeersch C, Medici AC, Narvaez R Peru-Universal health coverage for inclusive and sustainable development: country summary report 2014, World Bank Group, Washington, DC.
8. Herrera-Añazco P, Benites-Zapata VA, León-Yurivilca I, Huarcaya-Cotaquispe R, Silveira-Chau M Chronic kidney disease in Peru: a challenge for a country with an emerging economy. J Bras Nefrol 2015, 37:507-508.
9. Saran R, Hedgeman E, Plantinga L, et al. Establishing a national chronic kidney disease surveillance system for the United States. Clin J Am Soc Nephrol 2010, 5:152-161.
10. Ardiles LG, Poblete H, Ortiz M, et al. The health system in Chile: the nephrologist perspective. J Nephrol 2011, 24:149-154.
11. White SL, Chadban SJ, Jan S, et al. How can we achieve global equity in provision of renal replacement therapy?. Bull World Health Organ 2008, 86:229-237.
12. Sola L, Plata-Cornejo R, Fernandez-Cean J Latin American special project: kidney health cooperation project between Uruguay and Bolivia. Clin Nephrol 2015, 83:S21-S23.
13. Yang W, Hwang S Incidence, prevalence and mortality of dialysis end-stage renal disease in Taiwan from 1990-2001: the impact of national health insurance. Nephrol Dial Transplant 2008, 23:3977-3982. Taiwan Society of Nephrology.